Mood Disorders News

Older adults with higher levels of loneliness were at increased risk for more severe depression symptoms, according to results of a population-based cohort study published in The Lancet Psychiatry.

Prescription opioid use appeared to increase risk for depression, according to results of a mendelian randomization analysis published in JAMA Psychiatry.

Subjective happiness during ketamine infusion may be linked to a reduction in depressive symptoms during follow-up, according to study results published in Journal of Clinical Psychiatry.

Rates of anxiety and depression decreased among the general public and health workers of Wuhan, China, after the COVID-19 lockdown was eased, according to study results published in PLOS One.

Women with perinatal and postpartum depression likely benefit from the implementation of certain evidence-based strategies, according to a presenter at the NEI Max virtual conference.

A significant number of individuals report using cannabis to treat psychiatric and physical challenges, yet the evidence remains mixed on its efficacy, according to a presenter at the NEI Max virtual conference.

Mood disorders appeared linked to elevated and early rates of disability services, according to results of a cohort study published in JAMA Network Open.

Psychosocial and health-related risk factors, as well as socioeconomic position, were linked to risk for moderate to severe depressive symptoms during the COVID-19 pandemic, according to study results published in JAMA Network Open.

University students who experienced lockdowns due to COVID-19 exhibited a high prevalence of mental health issues, according to results of a survey study published in JAMA Network Open.

Co-prescribed benzodiazepines appeared to present treatment challenges among older adults with generalized anxiety disorder or major depressive disorder, according to study results published in Journal of Clinical Psychiatry.